Overview
Status
Suspended
Registry date
2022-06-14
Share capital
100,000.00 PLN
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Michał Tomasz Hazubski age 48 – President of the Management Board
Manner of representation
In the case of a one-person management board, the member of the management board is authorised to make declarations of will on behalf of the company independently. If the management board consists of two or more members, joint action of two members of the management board or of one member of the management board jointly with a commercial proxy is required to make declarations of will on behalf of the company.
Supervisory board
Małgorzata Katarzyna Grużewska age 42 – Supervisory Board Member
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 1,000,000 | $27,012.43 | 100% |
Beneficial owners
No beneficial owners recorded for the company Ergogenica.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Famicordtx S.A. | $1,365,068.41 | famicordtx.com | ||
| Proper Medical Writing sp. z o.o. | $464,661.64 | propermedicalwriting.com | ||
| Medicofarma Biotech S.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeutics sp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline Biosciences S.A. | $219,186.29 | frontlinebiosciences.com | ||
| Modica P.S.A. | $103,400.72 | modica.bio | ||
| Stenocoat sp. z o.o. | $36,665.21 | stenocoat.com | ||
| Biosel sp. z o.o. | $19,100.32 | selol.pl | ||
| Nawah Scientific Poland sp. z o.o. | – | nawah-scientific.com | ||
| LAST sp. z o.o. | – | last-skincare.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-04-29 | Address change (Ul. Krakowskie Przedmieście 13, 00-071, Warszawa → Warszawa) | |
| 2024-12-06 | Business suspended | |
| 2024-03-07 | Address change (Pl. Jana Kilińskiego 2, 33-005, Rzeszów → Ul. Krakowskie Przedmieście 13, 00-071, Warszawa) | |
| 2022-06-14 | Entered in the register |
FAQ
The main business activity of Ergogenica focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on June 14, 2022.
The headquarters is located at: Warszawa.
The management board consists of: Michał Tomasz Hazubski (President of the Management Board).
The share capital of the company is PLN 100,000 (approx. $27,012).
Last updated: 2026-04-29